BiomX Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
HLSQ$0.07-37.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Nine Months Ended | ||
|---|---|---|
| September 30, | ||
| 2025 | 2024 | |
| CASH FLOWS – OPERATING ACTIVITIES | ||
| Net loss | (22,862) | (3,214) |
| Adjustments required to reconcile cash flows used in operating activities: | ||
| Depreciation | 1,769 | 882 |
| Stock-based compensation | 1,793 | 1,083 |
| Finance expense (income), net | 266 | (478) |
| Revaluation of contingent consideration | (43) | 6 |
| Income from change in fair value of warrants | (1,682) | (24,417) |
| Private Placement Warrants issuance cost | - | 732 |
| Change in contract liability | - | (1,976) |
| Loss from sale and disposal of property and equipment, net | 165 | 145 |
| Goodwill impairment | - | 801 |
| Changes in operating assets and liabilities: | ||
| Other current assets | 1,752 | (213) |
| Trade accounts payable | (374) | (2,691) |
| Other accounts payable | (2,833) | (1,169) |
| Net change in operating leases | 45 | (181) |
| Net cash used in operating activities | (22,004) | (30,690) |
| CASH FLOWS – INVESTING ACTIVITIES | ||
| Cash and restricted cash acquired from the APT acquisition | - | 663 |
| Proceeds from sale of property and equipment | 109 | 72 |
| Purchases of property and equipment | (2) | (19) |
| Net cash provided by investing activities | 107 | 716 |
| CASH FLOWS – FINANCING ACTIVITIES | ||
| Issuance of Common Stock under February 2025 SPA | 996 | - |
| February 2025 SPA issuance costs | (118) | - |
| Issuance of Common Warrants under February 2025 SPA | 4,531 | - |
| Issuance of Common Stock under Inducement Letter Agreements | 6,473 | - |
| Issuance of Private Placement Warrants under March 2024 PIPE | - | 28,745 |
| Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE | - | 21,269 |
| March 2024 PIPE issuance costs | - | (507) |
| Pre-Funded Warrants and Common Warrants exercise | 2 | 6 |
| Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs | 54 | 19 |
| Issuance cost from the APT acquisition | - | (13) |
| Repayment of long-term debt | - | (10,747) |
| Net cash provided by financing activities | 11,938 | 38,772 |
| Increase (decrease) in cash and cash equivalents and restricted cash | (9,959) | 8,798 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 53 | (11) |
| Cash and cash equivalents and restricted cash at the beginning of the period | 17,975 | 15,864 |
| Cash and cash equivalents and restricted cash at the end of the period | 8,069 | 24,651 |
| RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS | ||
| Cash and cash equivalents | 6,923 | 23,537 |
| Restricted cash | 1,146 | 1,114 |
| Total cash and cash equivalents and restricted cash | 8,069 | 24,651 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
| Cash paid for interest | 15 | 1,437 |
| Taxes paid | 6 | 10 |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
| Lease liability and Operating lease right-of-use asset remeasurement | 2,487 | - |
| Property and equipment purchases included in other accounts payable and trade accounts payable | - | 11 |
| March 2024 PIPE issuance cost | - | 1,685 |
| Issuance of Common Stock under the APT acquisition | - | 3,041 |
| Issuance of Redeemable Convertible Preferred Shares under the APT acquisition | - | 12,610 |
| Issuance of Merger Warrants under the APT acquisition | - | 200 |
| Redeemable Convertible Preferred Shares conversion into shares of Common Stock | 28 | 13,774 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.